J A Brinker

Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Binding of tissue plasminogen activator to human umbilical vein endothelial cells

Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

Human vascular smooth muscle cells express an estrogen receptor isoform

Long-Term Estrogen Therapy Improves Vascular Function in Male to Female Transsexuals

Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery

Valvular Heart Disease

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

Glycosylation at Asn-184 inhibits the conversion of single-chain to two-chain tissue-type plasminogen activator by plasmin

Unstable angina: Pathogenesis, diagnosis, and treatment

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Percutaneous Repair or Surgery for Mitral Regurgitation

The Protective Effects of Estrogen on the Cardiovascular System

A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen

Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?

Unstable Angina Pectoris

SURGICAL OPTIONS FOR PATIENTS WITH ADVANCED EMPHYSEMA

Effect on Survival of Estrogen Replacement Therapy After Coronary Artery Bypass Grafting

The hemodynamic consequences of mechanical ventilation: an evolving story

Aortic Stenosis

Acute Renal Failure

Balloon aortic valvuloplasty

A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

How should we manage symptomatic aortic stenosis in the patient who is 80 or older?

Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

Aspirin, Heparin, or Both to Treat Acute Unstable Angina

Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction

Short-Term Effects of Transdermal Estrogen Replacement Therapy on Coronary Vascular Reactivity in Postmenopausal Women With Angina Pectoris and Normal Results on Coronary Angiograms

Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome

Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins

Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway.

Estrogen inhibits the response-to-injury in a mouse carotid artery model.

Heart???lung interactions

Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.

Estrogen plus Progestin and the Risk of Coronary Heart Disease

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial

Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina

Comparison of Hospital Mortality With Intra-Aortic Balloon Counterpulsation Insertion Before Versus After Primary Percutaneous Coronary Intervention for Cardiogenic Shock Complicating Acute Myocardial Infarction

Mechanisms, diagnosis, and treatment of diastolic heart failure

Production and Actions of Estrogens

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Obstructive Sleep Apnea as a Risk Factor for Stroke and Death

Atherosclerosis

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice

SLEEP APNEA IN CONGESTIVE HEART FAILURE

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

Myocarditis

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Sleep Apnea and Cardiovascular Disease

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Myocardial reperfusion: a double-edged sword?

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis

17β-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.

Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.

The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women

Silent Ischemia as a Marker for Early Unfavorable Outcomes in Patients with Unstable Angina

Studies of controlled reperfusion after ischemia

Guidelines for the early management of patients with acute myocardial infarction

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Conjugated Estrogens Acutely Abolish Abnormal Cold-Induced Coronary Vasoconstriction in Male Cardiac Allografts

Sexually Dimorphic Response of the Balloon-Injured Rat Carotid Artery to Hormone Treatment

Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Contrasting Effects of Conjugated Estrogens and Tamoxifen on Dilator Responses of Atherosclerotic Epicardial Coronary Arteries in Nonhuman Primates

Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

Targeting G _βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal.

Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome

Nongenomic Steroid Action: Controversies, Questions, and Answers

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

Glycobiology:  Toward Understanding the Function of Sugars

Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.

The vascular protective effects of estrogen

SPECIFIC, NONGENOMIC ACTIONS OF STEROID HORMONES

Purification and characterization of recombinant single-chain urokinase produced in Escherichia coli

An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Identification of Authentic Estrogen Receptor in Cultured Endothelial Cells

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

17β-Estradiol Regulation of Human Endothelial Cell Basal Nitric Oxide Release, Independent of Cytosolic Ca ²⁺ Mobilization

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Mechanism of Vascular Smooth Muscle Relaxation by Estrogen in Depolarized Rat and Mouse Aorta

ESTROGENS AND ATHEROSCLEROSIS

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart

Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.

17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

Premature Coronary Artery Disease Associated With a Disruptive Mutation in the Estrogen Receptor Gene in a Man

Estrogen Restores Endothelial Cell Function in an Experimental Model of Vascular Injury

Antiatherogenic Effect of Estrogen Abolished by Balloon Catheter Injury in Cholesterol-Clamped Rabbits

Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice

Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.

Frequency and determinants of adverse reactions induced by high-osmolality contrast media.

A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty

ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization.

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.

Leftward septal displacement during right ventricular loading in man.

Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans.

Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina.

Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations.

Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.